APTAPHARMA INC FDA Approval ANDA 216953

ANDA 216953

APTAPHARMA INC

FDA Drug Application

Application #216953

Application Sponsors

ANDA 216953APTAPHARMA INC

Marketing Status

Prescription001

Application Products

001SOLUTION;ORALEQ 20MG BASE/5ML0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-11-15STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

APTAPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216953
            [companyName] => APTAPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 20MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/15\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-15
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.